• 1
    Hser Y, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001; 58:5038.
  • 2
    Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, et al. The characteristics of heroin users entering treatment: Findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev. 2005; 24:4118.
  • 3
    Boutwell AE, Nijhawan A, Zaller N, Rich JD. Arrested on heroin: A national opportunity. J Opioid Manag. 2007; 3:32832.
  • 4
    Pettit B, Lyons CJ. Incarceration and the legitimate labor market: Examining age-graded effects on employment and wages. Law Soc Rev. 2009; 43:72556.
  • 5
    Massoglia M. Incarceration as exposure: The prison, infectious disease, and other stress-related illnesses. J Health Soc Behav. 2008; 49(1): 5671.
  • 6
    Falster K, Kaldor J, Maher L. Hepatitis C Virus Acquisition among Injecting Drug Users: A Cohort Analysis of a National Repeated Cross-sectional Survey of Needle and Syringe Program Attendees in Australia, 1995–2004. J Urban Health. 2009; 86(1): 10618.
  • 7
    Miller ER, Hellard ME, Bowden S, Bharadwaj M, Aitken CK. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. J Infect. 2009; 58(5): 37582.
  • 8
    Merrall ELC, Kariminia A, Binswanger IA, Hobbs M, Farrell M, Marsden J, et al. Meta-analysis of drug-related deaths soon after release from prison. Addiction. 2010; 105:154554.
  • 9
    Butler T, Milner L. The 2001 New South Wales Inmate Health Survey. Sydney (AUST): Corrections Health Service;2003.
  • 10
    Indig D, Wales NS. 2009 NSW Inmate Health Survey: Key Findings Report. Sydney (AUST): Justice Health Centre for Health Research in Criminal Justice;2010.
  • 11
    Phillips B, Burns L. NSW Drug Trends 2011: Findings from the Illicit Drug Reporting System. Sydney (AUST): National Drug and Alcohol Research Centre;2012.
  • 12
    Productivity Commission. Review of Government Service Provision. Canberra (AUST): Commonwealth of Australia;2012.
  • 13
    Degenhardt L, Gisev N, Trevena J, Larney S, Kimber J, Burns L, et al. Engagement with the criminal justice system among opioid-dependent people: Retrospective cohort study. Addiction. 2013. doi: 10.1111/add.12324.
  • 14
    Kinner SA, Jenkinson R, Gouillou M, Milloy MJ. High-risk drug-use practices among a large sample of Australian prisoners. Drug Alcohol Depend. 2012; 126 (1–2): 15660.
  • 15
    Calzavara LM, Burchell AN, Schlossberg J, Myers T, Escobar M, Wallace E, et al. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction. 2003; 98(9): 125765.
  • 16
    Strang J, Gossop M, Heuston J, Green J, Whiteley C, Maden A. Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison. Addiction. 2006; 101(8): 112532.
  • 17
    Dolan K, Teutsch S, Scheuer N, Levy M, Rawlinson W, Kaldor J, et al. Incidence and risk for acute hepatitis C infection during imprisonment in Australia. Eur J Epidemiol. 2010; 25:1438.
  • 18
    Gisev N, Burns L, Larney S, Doyle M, Clifford A, Williams M, Gibson A, Kimber J, Butler T, Mattick R, Degenhardt L. Engagement with the criminal justice system among opioid-dependent people: Comparison between Indigenous and non-Indigenous offenders. National Drug and Alcohol Research Centre 2013 Annual Symposium. 4 September 2013. Sydney, Australia.
  • 19
    Weatherburn D, Holmes J. Re-thinking Indigenous over-representation in prison. Aust J Soc Issues. 2010; 45:55976.
  • 20
    Wan WY, Moffatt S, Jones C, Weatherburn D. The Effect of Arrest and Imprisonment on Crime. Contract No.: 158. Sydney (AUST): New South Wales Bureau of Crime Statistics and Research; 2012.
  • 21
    Aos S, Miller M, Drake E. Evidence-based Public Policy Options to Reduce Future Prison Construction, Criminal Justice Costs, and Crime Rates. Olympia (WA): Washington State Institute for Public Policy;2006.
  • 22
    Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence (Cochrane Review). In: Cochrane Database of Systematic Reviews, Issue 3, Artical No.: CD002209. Chichester (UK): Wiley and Sons; 2009.
  • 23
    Milloy MJ, Wood E, Small W, Tyndall M, Lai C, Montaner J, et al. Incarceration experiences in a cohort of active injection drug users. Drug Alcohol Rev. 2008; 27(6): 6939.
  • 24
    Werb D, Kerr T, Marsh D, Li K, Montaner J, Wood E. Effect of methadone treatment on incarceration rates among injection drug users. Eur Addict Res. 2008; 14:1439.
  • 25
    Moore TJ, Ritter A, Caulkins JP. The costs and consequences of three policy options for reducing heroin dependency. Drug Alcohol Rev. 2007; 26:36978.
  • 26
    Bukten A, Skurtveit S, Gossop M, Waal H, Stangeland P, Havnes I, et al. Engagement with opioid maintenance treatment and reductions in crime: A longitudinal national cohort study. Addiction. 2011; 107:3939.
  • 27
    Lind B, Chen SL, Weatherburn D, Mattick RP. The effectiveness of methadone maintenance in controlling crime: An Australian aggregate-level analysis. Br J Criminol. 2005; 45:20111.
  • 28
    Oliver P, Keen J, Rowse G, Ewins E, Griffiths L, Mathers N. The effect of time spent in treatment and dropout status on rates of convictions, cautions and imprisonment over 5 years in a primary care-led methadone maintenance service. Addiction. 2010; 105:7329.
  • 29
    MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis. BMJ. 2012; 345:e5945.
  • 30
    Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved. Drug Alcohol Depend. 2009; 105:915.
  • 31
    Dolan K, Shearer J, MacDonald M, Mattick RP, Hall W, Wodak A. A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend. 2003; 72(1): 5965.
  • 32
    Larney S, Toson B, Burns L, Dolan K. Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration. Addiction. 2012; 107:37280.
  • 33
    Larney S, Burns L. Evaluating health outcomes of criminal justice populations using record linkage: The importance of aliases. Eval Rev. 2011; 35:11828.